Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 190

The DOI matches its Crossref record.

MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1

Open access
Bier, Ariel, Giladi, Nis, Kronfeld, Noam, Lee, Hae Kyung, Cazacu, Simona, Finniss, Susan, Xiang, Cunli, Poisson, Laila, deCarvalho, Ana C., Slavin, Shimon, Jacoby, Elad, Yalon, Michal, Toren, Amos, Mikkelsen, Tom, Brodie, Chaya·2013·Oncotarget

Abstract

// Ariel Bier, 1 Nis Giladi, 1 Noam Kronfeld, 1 Hae Kyung Lee, 2 Simona Cazacu, 2 Susan Finniss, 2 Cunli Xiang, 2 Laila Poisson, 3 Ana C. deCarvalho 2 , Shimon Slavin 4 , Elad Jacoby, 5 Michal Yalon, 5 Amos Toren, 5 Tom Mikkelsen 2 and Chaya Brodie 1,2 1 Everard and Mina Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel, 2 Davidson Laboratory of Cell Signaling and Tumorigenesis, Hermelin Brain Tumor Center, Department of Neurosurgery, Henry Ford Hospital, Detroit MI USA. 3 Department of Public Health Sciences, Tel Aviv, Israel 4 The International Center for Cell Therapy and Cancer Immunotherapy (CTCI), Tel Aviv, Israel, 5 Pediatric Hemato-Oncology, The Edmond and Lilly Safra Children’s Hospital, Sheba Medical Center, Tel-Hashomer and The Sackler School of Medicine, Tel-Aviv University, Israel. Correspondence: Chaya Brodie, email: // Keywords : Glioma stem cells, self renewal, miR-137, RTVP-1, CXCR4 Received : March 12, 2013 Accepted : April 7, 2013 Published : April 9, 2013 Abstract Glioblastomas (GBM), the most common and aggressive malignant astrocytic tumors, contain a small subpopulation of cancer stem cells (GSCs) that are implicated in therapeutic resistance and tumor recurrence. Here, we study the expression and function of miR-137, a putative suppressor miRNA, in GBM and GSCs. We found that the expression of miR-137 was significantly lower in GBM and GSCs compared to normal brains and neural stem cells (NSCs) and that the miR-137 promoter was hypermethylated in the GBM specimens. The expression of miR-137 was increased in differentiated NSCs and GSCs and overexpression of miR-137 promoted the neural differentiation of both cell types. Moreover, pre-miR-137 significantly decreased the self-renewal of GSCs and the stem cell markers Oct4, Nanog, Sox2 and Shh. We identified RTVP-1 as a novel target of miR-137 in GSCs; transfection of the cells with miR-137 decreased the expression of RTVP-1 and the luciferase activity of RTVP-1 3’-UTR reporter plasmid. Furthermore, overexpression of RTVP-1 plasmid lacking its 3’-UTR abrogated the inhibitory effect of miR-137 on the self-renewal of GSCs. Silencing of RTVP-1 decreased the self-renewal of GSCs and the expression of CXCR4 and overexpression of CXCR4 abrogated the inhibitory effect of RTVP-1 silencing on GSC self-renewal. These results demonstrate that miR-137 is downregulated in GBM probably due to promoter hypermethylation. miR-137 inhibits GSC self-renewal and promotes their differentiation by targeting RTVP-1 which downregulates CXCR4. Thus, miR-137 and RTVP-1 are attractive therapeutic targets for the eradication of GSCs and for the treatment of GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.928

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Bier, A., Giladi, N., Kronfeld, N., Lee, H. K., Cazacu, S., Finniss, S., Xiang, C., Poisson, L., deCarvalho, A. C., Slavin, S., Jacoby, E., Yalon, M., Toren, A., Mikkelsen, T., & Brodie, C.
Venue
Oncotarget
Published
2013-04-09
Volume
4
Issue
5
Pages
665-676
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2097494801
Cited by
190
References
0
FWCI
11.38
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.